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Midline 1 (MID1) is a microtubule-associated ubiquitin ligase that regulates protein phos-
phatase 2A activity. Loss-of-function mutations in MID1 lead to the X-linked Opitz G/BBB
syndrome characterized by defective midline development during embryogenesis. Here,
we show that MID1 is strongly upregulated in murine cytotoxic lymphocytes (CTLs), and
that it controls TCR signaling, centrosome trafficking, and exocytosis of lytic granules.
In accordance, we find that the killing capacity of MID1−/− CTLs is impaired. Transfec-
tion of MID1 into MID1−/− CTLs completely rescued lytic granule exocytosis, and vice
versa, knockdown of MID1 inhibited exocytosis of lytic granules in WT CTLs, cementing
a central role for MID1 in the regulation of granule exocytosis. Thus, MID1 orchestrates
multiple events in CTL responses, adding a novel level of regulation to CTL activation and
cytotoxicity.
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Introduction
Cytotoxic lymphocytes (CTLs) play a key role in the defense
against infections. The CTL recognizes specific antigen/MHC
complexes on infected target cells by the TCR. Specific recog-
nition of a target cell leads to establishment of a stable con-
jugation, the immunological synapse (IS), between the CTL
and the target cell [1–3]. Immediately after recognition of the
target cell, the CTL polarizes its secretory machinery toward
the IS. The centrosome, which in CTLs is often called the
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microtubule-organizing center (MTOC), relocates to the IS [4, 5],
and lytic granules that contain perforin and granzymes move
along the microtubules toward the MTOC [6]. Here, they dock
at the plasma membrane and deliver their content by exocyto-
sis into the small secretory cleft of the IS [3, 7, 8]. Perforin
and granzymes subsequently act in concert to induce apopto-
sis of the target cell [9]. Thus, the microtubule cytoskeleton
plays a key role in directional secretion of lytic granules and
thereby in CTL-mediated target cell killing [8]. It is still not clear
how CTLs regulate reorganization of the microtubule cytoskele-
ton and exocytosis of lytic granules during encounter with target
cells.
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Midline 1 (MID1) is a ubiquitin ligase that belongs to the
RBCC/TRIM family, which contains a RING domain followed by
B-boxes and a coiled-coil domain [10, 11]. MID1 is associated with
the microtubules [12, 13] and regulates the level of microtubule-
associated protein phosphatase 2A (PP2A) [14, 15]. The X-linked
Opitz G/BBB syndrome (OS) is caused bymutations ofMID1 and is
characterized by disorders that primarily affect the ventral midline
[16]. Manifestations include ocular hypertelorism, genitourinary
defects, clefts of palate and lip, trachea-esophageal fistulas, imper-
forate anus, and mental retardation. An accumulation of the cat-
alytic subunit of PP2A (PP2Ac) is found in fibroblasts from patients
with OS due to impairment of the ubiquitin ligase activity of the
mutated MID1. The increased level of PP2Ac is associated with
reduced phosphorylation of microtubule-associated proteins that
regulate microtubule dynamics [14]. From these observations, it
has been suggested that MID1 plays crucial roles during embryo-
genesis by regulating microtubule dynamics [10, 17].
Whether MID1 plays any role after embryogenesis has
remained unknown until very recently, when it was found that
MID1 is involved in induction of allergic airway inflammation
in the bronchial epithelium [18]. Whether MID1 is expressed in
T cells is unknown. As microtubule dynamics play key roles in
CTL polarization and target cell killing, and as MID1 has been
suggested to control microtubule dynamics during embryogen-
esis, we asked the question of whether MID1 is expressed in
T cells and what function it might play in CTLs. We purified na¨ıve
and activated T cells and found that MID1 is indeed expressed in
T cells and that it is highly upregulated in CTLs. To determine
the biological function of MID1 in CTLs, we studied lymphocytic
choriomeningitis virus (LCMV) specific T cells from P14 TCR trans-
genic mice and P14 mice crossed to MID1−/− mice (P14MID1−/−
mice). We found that whereas the level of PP2Ac rapidly declined
in P14 CTL following activation, it was unaffected by activation
in P14MID1−/− CTLs. In parallel, we found affected TCR signal-
ing and impaired polarization of the MTOC during activation of
P14MID1−/− CTLs with concomitant reduced exocytosis of lytic
granules and cytotoxicity. Transfection of MID1 into P14MID1−/−
CTLs completely rescued lytic granule exocytosis and, in
accordance, knockdown of MID1 inhibited exocytosis of the lytic
granules in P14 CTLs.
Results
CD8+ T cells upregulate MID1 expression in response
to TCR stimulation
During embryogenesis, MID1 is widely expressed, whereas in
adult tissues it is mainly found in the brain, heart, kidney, lung,
and placenta and only weakly expressed in thymus and spleen
[16, 19–21]. It is not known whetherMID1 is expressed in T cells.
To address this question, we determined MID1 mRNA expres-
sion in T cells during their development and differentiation by
purification of thymocytes from C57BL/6 mice and na¨ıve CD4+
and CD8+ T cells from TCR transgenic SMARTA and P14 mice,
respectively. Activated CD4+ and CD8+ (hereafter termed CTLs)
T cells were generated by stimulation of CD4+ and CD8+ T cells
with LCMV glycoprotein gp61–80 and gp33–41, respectively. MID1
mRNA expression was low in thymocytes and na¨ıve CD4+ and
CD8+ T cells. Activation of CD4+ T cells did not significantly affect
MID1 mRNA expression. In contrast, MID1 mRNA expression was
strongly upregulated in CTLs (Fig. 1A). To study the kinetics of
activation-induced MID1 upregulation in CD8+ T cells, we stim-
ulated CD8+ T cells from P14 mice for 3 days, rested them for
2 days and finally restimulated them for 1 or 2 h. At each time
point, we purified the CD8+ T-cell population, measured theMID1
mRNA expression, and calculated the fold change ofMID1 expres-
sion relative to MID1 expression in na¨ıve CD8+ T cells. We found
that MID1 mRNA expression increased seven- to eightfold dur-
ing the first days of activation (Fig. 1B). During the rest period,
MID1 mRNA expression slightly declined; however, MID1 expres-
sion rapidly increased following restimulation of the CTLs. Taken
together, these results show that MID1 is weakly expressed in
na¨ıve T cells, and that it becomes strongly upregulated in CTLs.
MID1 does not affect T-cell development and CTL
expansion
To determine the biological function of MID1 in CTLs, we
studied LCMV-specific T cells from P14 TCR transgenic mice and
P14 mice crossed to MID1 KO mice (P14MID1−/− mice). First, we
compared the distribution of lymphocytes in thymus, spleen, and
LNs from P14 and P14MID1−/− mice. We found that the distribu-
tion of CD4+ and CD8+ T cells and CD19+ B cells was unaffected
in all organs tested in P14MID1−/− mice (Supporting Information
Fig. 1). Furthermore, the total number of thymocytes was unaf-
fected in P14MID1−/− mice. These results show that MID1 does
not affect T-cell development.
To analyze whether MID1 affects activation, expansion, and
differentiation of CD8+ T cells, we stimulated splenocytes from
P14 and P14MID1−/− mice with gp33–41 from 0 to 6 days. We did
not find any differences in proliferation or expansion of T cells
Figure 1. MID1 mRNA expression in T cells. (A) Quantitative PCR anal-
ysis of MID1 is shown for murine thymocytes, naı¨ve CD4+ and CD8+
T cells, and activated CD4+ T cells and CTLs. (B) CD8+ T cells were
stimulated for 0–72 h, rested for 2 days (96 and 120 h) and restimulated
for 1 and 2 h (+1 and +2). The mRNA levels of MID1 were normalized
to (A) β-actin or to (B) MID1 in naı¨ve CD8+ T cells. Data are shown as
mean of three replicates from a single experiment representative of
five independent experiments.
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Figure 2. MID1 is not required for
CTL expansion and differentiation.
(A) Proliferation of P14 (black squares)
and P14MID1−/− (white squares) CTLs
as measured by 3H-thymidine incor-
poration. The data are shown as
mean ± SEM of six samples pooled
from two independent experiments.
(B) Expansion of P14 and P14MID1−/−
CTLs as measured by the fraction of
CD8+Vα2+ cells in the cell cultures
by flow cytometry. (C) CTL differen-
tiation as measured by the fraction
of CD44highCD62Llow, (D) granzyme B+,
(E) IFN-γ+, and (F) TNF-α+ of the
CD8+Vα2+ cells by flow cytometry. (B–
F) The data are shown as mean ± SEM
of three to six mice pooled from three
independent experiments. For FACS
gating strategy, please see Supporting
Information Figure 1.
from P14 and P14MID1−/− mice as measured by 3H-thymidine
incorporation or fraction of CD8+Vα2+ transgenic CD8+ T cells
in the cell cultures (Fig. 2A and B). Likewise, the P14 and
P14MID1−/− transgenic CD8+ T cells differentiated into CTLs with
similar kinetics as determined by upregulation of CD44, down-
regulation of CD62L, and expression of granzyme B, perforin,
IFN-γ, and TNF-α (Fig. 2C–F and Supporting Information Fig. 2).
These results demonstrate that MID1 does not play a significant
role in activation of na¨ıve CD8+ T cells and their subsequent dif-
ferentiation into CTLs.
MID1 controls TCR signaling and MTOC polarization
in CTLs
A marked accumulation of PP2Ac is found in fibroblasts from
patients with OS due to an impairment of the ubiquitin ligase
activity of the mutated MID1 that normally targets PP2Ac for
degradation [14]. To examine whether MID1 regulates the level
of PP2Ac in CTLs, we restimulated P14 and P14MID1−/− CTLs
for 0–6 h and subsequently determined the level of PP2Ac in the
cells. We did not find any difference in the levels of PP2Ac in
resting P14 and P14MID1−/− CTLs (Fig. 3A). However, following
stimulation, a vigorous downregulation of PP2Ac was seen in P14
CTLs, whereas the level of PP2Ac was unaffected by stimulation in
P14MID1−/− CTLs (Fig. 3A and B). These results show that MID1
regulates PP2Ac levels during activation of CTLs.
PP2A belongs to the family of serine/threonine phosphatases
that regulates a large variety of cellular processes [22, 23],
and PP2A activity is involved in the control of several signaling
pathways including the mitogen-activated protein kinase pathway
[24], a key pathway in TCR-induced signaling [25]. To examine
whether MID1 affects TCR signaling in CTL, we measured phos-
phorylation of ZAP70, ERK1/2, and S6K1 (ribosomal S6 protein
kinase 1) in P14 and P14MID1−/− CTLs stimulated for 0–2 h. Prox-
imal TCR signaling as determined by phosphorylation of ZAP70
was unaffected in P14MID1−/− CTLs. In contrast, more distal TCR
signaling as determined by ERK1/2 and S6K1 phosphorylation
was significantly impaired in P14MID1−/− CTLs (Fig. 3C and D).
Polarization of the MTOC to the IS is required for direc-
tional secretion of lytic granules and target cell killing [26].
MTOC polarization is initiated within minutes of TCR stimulation
and is regulated by a number of signaling molecules including
ERK1/2 [8]. To examine whether MID1 affected MTOC polariza-
tion, we incubated live P14 and P14MID1−/− CTLs on coverslips
coated with anti-CD3 antibodies at 37°C for 20 min and sub-
sequently determined the position of the MTOC relative to the
surface of the coverslips by spinning disc microscopy (Fig. 3E).
We found that MTOC polarization toward the anti-CD3-coated
surface was significantly impaired in P14MID1−/− CTLs compared
to P14 CTLs (p = 0.0011) (Fig. 3F and Supporting Information
Fig. 3). To substantiate that MID1 regulates MTOC polarization,
we then studied MTOC polarization following shRNA-mediated
knockdown of MID1. P14 CTLs were transfected with shMID1-
GFP plasmids, sorted into a shMID1-GFP+ and a shMID1-GFP−
subpopulation, and incubated on anti-CD3-coated coverslips. The
MTOC position was determined by spinning disc microscopy as
described above. MTOC polarization was significantly reduced
in the shMID1-GFP− P14 CTLs transfectants compared with the
shMID1-GFP+ P14 CTLs transfectants (Fig. 3G). Finally, by trans-
fecting MID1-GFP into P14MID1−/− CTLs, MTOC polarization was
rescued (Fig. 3H), whereas transfection of P14 CTLs with MID1-
GFP did not affect MTOC polarization (data not shown). Taken
together, these results show that MID1 regulates distal TCR sig-
naling and MTOC polarization in CTLs.
MID1 regulates CTL cytotoxicity and granzyme B
exocytosis
Efficient CTL-mediated target cell killing depends on polarization
of the MTOC to the IS and subsequent trafficking of the lytic
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Figure 3. MID1 controls TCR signaling and MTOC
polarization. (A, B) P14 and P14MID1−/− CTLs were
stimulated with gp33–41 for the time indicated and
PP2Ac levels were determined by Western blot.
(C, D) P14 and P14MID1−/− CTLs were stimulated
with gp33–41 for the time indicated and the lev-
els of pZAP70, pERK1/2, and pS6K1 were deter-
mined by Western blot. (A, C) Data shown are
representative of four independent experiments;
(B, D) semiquantification for these experiments
are shown. (E) Localization of the MTOC rela-
tive to the anti-CD3-coated coverslip was per-
formed by spinning disc microscopy. Shown is
a side view of a representative CTL from four
independent experiments stained with Tubulin
Tracker. The position of the MTOC (arrow) is indi-
cated with a red dot at the ordinate that gives
the relative MTOC position. Scale bar is 5 μm.
(F) The relative MTOC position and mean value
for P14 (n = 253) and P14MID1−/− (n = 231) CTLs
from four independent experiments are shown.
(G) Relative MTOC position and mean value for
shMID1-GFP− (n = 74) and shMID1-GFP+ (n =
43) P14 CTL transfectants from two indepen-
dent experiments. (H) RelativeMTOCposition and
mean values for MID1-GFP− (n = 148) and MID1-
GFP+ (n = 72) P14MID1−/− CTL transfectants from
two independent experiments. (F–G) p < 0.05;
p < 0.01; and p < 0.001, Mann–Whitney test.
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Figure 4. MID1 regulates CTL cytotoxic-
ity and granzyme B exocytosis. (A) The
fraction of dead target cells co-cultured
with P14 (black squares) or P14MID1–/–
(white squares) CTLs at the indicated effec-
tor:target (E:T) cell ratios was determined
by flow cytometry. The data are shown as
mean + SEM of four to six samples pooled
from four independent experiments.
(B–D) The concentrations of (B) granzyme B,
(C) IFN-γ, and (D) TNF-α in the supernatants
of P14 or P14MID1–/– CTLs co-cultured with
peptide-pulsed splenocytes for 4 h was
determined by ELISA. (B–D) The data are
shown as mean ± SEM of three to ten mice
pooled from three to five independent
experiments. Each square represents data
from one individual mouse. p < 0.05,
p < 0.01, Student’s t-test.
granules along the microtubules to the IS [7, 8, 27]. In accor-
dance, agents that depolymerize microtubules inhibit exocytosis of
lytic granules and target cell killing [5, 28]. To examine whether
MID1 affects CTL-mediated cytotoxicity, we incubated P14 and
P14MID1−/− CTLs with gp33–41 pulsed EL-4 target cells. Since
P14 and P14MID1−/− CTLs differentiated with identical kinetics
and expressed equivalent levels of granzyme B, perforin, IFN-γ,
and TNF-α (Supporting Information Fig. 2), we could directly
compare these cell populations in cytotoxicity assays. CTLs and the
target cells were spun together in round-bottomed plates to avoid
any influence of cell migration on CTL-target cell conjugation.
By using this procedure, equal numbers of P14 and P14MID1−/−
CTL-target cell conjugates were formed (Supporting Information
Fig. 4). The cytotoxicity assay revealed that the cytotoxic capac-
ity of P14MID1−/− CTLs was reduced by approximately 30%
compared with P14 CTLs (Fig. 4A). Next, we investigated whether
the reduced target cell killing by P14MID1−/− CTLs could be
attributed to different kinetics in the cytotoxicity of P14 and
P14MID1−/− CTLs. However, this was not the case. The vastmajor-
ity of target cell killing took place between 1 and 2 h of incubation
and did not significantly increase for P14 or P14MID1−/− CTLs
by extending the culture period to 4 h (Supporting Information
Fig. 5).
To identify the cytotoxic pathway responsible for the impaired
cytotoxicity, we then studied exocytosis of the lytic granules. The
reduced ability to kill target cells via lytic granules could be due
to diminished expression of perforin/granzyme, impaired exo-
cytosis of the lytic granules, or a combination of the two. As
we did not observe any differences in the expression levels of
granzyme B and perforin in P14 and P14MID1−/− CTLs (Sup-
porting Information Fig. 2), we determined exocytosis of lytic
granules as measured by granzyme B secretion. We cultured P14
and P14MID1−/− CTLs with gp33–41 pulsed splenocytes for 4 h
and subsequently measured the concentration of granzyme B in
the supernatants. P14MID1−/− CTLs secreted approximately 25%
less granzyme B than P14 CTLs (Fig. 4B). To assess whether other
secretory pathways were affected by MID1, we measured IFN-γ
and TNF-α in the same supernatants. In contrast to granzyme B
secretion, P14 and P14MID1−/− CTLs secreted equivalent amounts
of IFN-γ and TNF-α (Fig. 4C and D). It has been proposed
that upregulation of CD107a (LAMP1) on CTL correlates with
exocytosis of lytic granule and cytotoxicity [29]. We therefore
stimulated P14 and P14MID1−/− CTLs for 60–240 min in the
presence of anti-CD107a antibodies and subsequently determined
CD107a upregulation by FACS analysis. In agreement with the
reduced granzyme B secretion, we found a reduced upregulation
of CD107a in P14MID1−/− CTLs compared to P14 CTLs (Support-
ing Information Fig. 5G). Taken together, these results show that
MID1 controls CTL-mediated cytotoxicity most likely by regulating
exocytosis of the lytic granules.
MID1 controls exocytosis of lytic granules
If MID1 controls exocytosis of lytic granules, re-expression of
MID1 into P14MID1−/− CTLs should rescue the exocytosis defect
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Figure 5. MID1 controls exocytosis of lytic granules. (A–C) The concentration of (A) granzyme B, (B) IFN-γ, and (C) TNF-α in the supernatants of
MID1-GFP− andMID1-GFP+ P14 or P14MID1–/– CTL transfectants co-cultured with peptide-pulsed splenocytes for 4 h was determined by ELISA. The
values were normalized to secretion by the MID1-GFP− P14 CTL transfectants. (A–C) Data are shown as mean + SEM of three to ten mice pooled
from three to five independent experiments. (D–E) The concentration of (D) granzyme B and (E) IFN-γ in the supernatants of shMID1-GFP− and
shMID1-GFP+ P14 CTL transfectants co-cultured with peptide-pulsed splenocytes for 4 h was determined by ELISA. The values were normalized to
secretion by the shMID1-GFP− P14 CTL transfectants. Data are shown asmean+ SEM of three samples pooled from three independent experiments.
(F) Quantitative PCR analysis ofMID1 in shMID1-GFP− and shMID1-GFP+ P14 CTL transfectants. The mRNA levels ofMID1were normalized toMID1
in shMID1-GFP− P14 CTL transfectants. The data are shown as mean of three replicas and are from a single experiment representative of two
independent experiments. p < 0.05, Student’s t-test.
of P14MID1−/− CTLs. Consequently, we transfected P14 and
P14MID1−/−CTLs with a MID1-GFP plasmid. The transfected cells
were sorted in an MID1-GFP+ and an MID1-GFP− subpopula-
tion and then stimulated for 4 h with gp33–41 pulsed spleno-
cytes. The supernatants were harvested and the concentration of
secreted granzyme B, IFN-γ, and TNF-α determined. Transfection
of MID1 into P14MID1−/− CTLs completely rescued granzyme B
exocytosis and even increased it almost twofold compared with
granzyme B exocytosis by MID1-GFP− P14 CTLs (Fig. 5A). Like-
wise, transfected MID1 also significantly increased granzyme B
exocytosis in P14 CTLs. In contrast, neither IFN-γ nor TNF-α
secretion was affected by MID1 transfection (Fig. 5B and C).
To exclude that GFP in itself affected granzyme B exocytosis we
transfected P14 CTLs with a control-GFP plasmid, sorted the trans-
fected cells in a control-GFP+ and a control-GFP− subpopulation
and stimulated them for 4 h with gp33–41 pulsed splenocytes and
measured granzyme B in the supernatants. We found that GFP
expression did not affect granzyme B exocytosis (Supporting Infor-
mation Fig. 6).
To substantiate that MID1 controls exocytosis of lytic granules,
we studied granule exocytosis following shRNA-mediated knock-
down of MID1. P14 CTLs were transfected with shMID1-GFP
plasmids, sorted into a shMID1-GFP+ and an shMID1-GFP−
subpopulation, and stimulated for 4 h with gp33–41 pulsed spleno-
cytes. The supernatants were harvested and the concentration
of secreted granzyme B and IFN-γ determined. Secretion of
granzyme B was reduced by approximately 70% in shMID1-GFP+
P14 CTLs compared with shMID1-GFP− P14 CTLs, whereas IFN-γ
secretion was unaffected by MID1 knockdown (Fig. 5D and E).
QPCR analyses demonstrated that MID1 expression was reduced
by approximately 50% in shMID1-GFP+ P14 CTLs compared with
shMID1-GFP− P14 CTLs (Fig. 5F). Taken together, these results
show that MID1 controls exocytosis of lytic granules in CTLs.
Discussion
In this study, we show that MID1 controls exocytosis of lytic
granules and cytotoxicity in CTL.MID1 is amicrotubule-associated
ubiquitin ligase that regulates the level of microtubule-associated
PP2Ac in embryonic fibroblasts [12–15]. MID1 is causally linked
to OS and plays important roles in the formation of diverse ventral
midline structures during embryogenesis [16]. Whether MID1 is
expressed in T cells or plays any biological role in these was not
known until the present study.
We found that MID1 mRNA is weakly expressed in murine
thymocytes and na¨ıve T cells. This is in good agreement with
C© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
Eur. J. Immunol. 2014. 44: 3109–3118 Molecular immunology 3115
previous studies, which found that although MID1 is widely
expressed during embryogenesis, it is mainly found in the brain,
heart, kidney, lung, and placenta and only weakly expressed in
thymus and spleen in adult tissues [16, 20, 21]. The low expres-
sion ofMID1 in thymocytes also concurs with our observation that
T-cell development is not affected in P14MID1−/− mice. Likewise,
the weak MID1 expression in na¨ıve T cells might also explain why
activation and expansion of na¨ıve P14MID1−/− T cells were unaf-
fected. We show that MID1 becomes significantly upregulated fol-
lowing activation and differentiation of mouse CD8+ T cells. The
activation-induced upregulation of MID1 was specific for CD8+
T cells and was not seen in CD4+ T cells. Differential gene expres-
sion in activated CD4+ and CD8+ T cells, as observed for MID1
in this study, is not exceptional but has been reported for several
genes including Prf1 (perforin) and Gzmb (granzyme B) [30].
Recently, it has been described that fibroblasts derived from
OS patients harboring a mutated MID1 have defects in mTORC1
function as measured by impaired phosphorylation of S6K1 [27].
In parallel, it was found that knockdown of MID1 in the human
osteosarcoma cell line U2OS reduced mTORC1 function and S6K1
phosphorylation. In accordance, we found that MID1 affected TCR
signaling, and that S6K1 phosphorylation was strongly impaired
in P14MID1−/− CTLs. Activation of ERK1/2 was also impaired
in P14MID1−/− CTLs, whereas proximal TCR signaling as deter-
mined by ZAP70 phosphorylation was unaffected. PP2A plays a
major role in down regulation of ERK1/2 activity [31] and our
results strongly indicate that the PP2A activity in P14MID1−/−
CTLs is increased as previously observed in fibroblasts from
OS patients [14]. This was further supported by the increased
levels of PP2Ac in stimulated P14MID1−/− CTLs. The reverse
scenario where MID1 upregulation leads to PP2A downregula-
tion has recently been described in relation to airway inflamma-
tion [18] and Huntington’s disease [32]. Whether the impaired
mTORC1 function we observed as reduced S6K1 phosphoryla-
tion in P14MID1−/− CTLs is caused by a direct inhibitory effect
of PP2A on mTORC1, as suggested for MID1-deficient cell lines
[27], or indirectly via increased TSC2 activity caused by the
reduced ERK1/2 activity [33] or by other mechanisms requires
further studies to be determined. The molecular mechanisms that
drive MTOC polarization are poorly understood; however, sev-
eral molecules in the TCR signaling pathways including ERK1/2
[8, 34] have been implicated in MTOC polarization to the IS. In
accordance with the affected TCR signaling and reduced ERK1/2
activation, we found that polarization of the MTOC was impaired
in P14MID1−/− CTLs. In line with this, shRNA-mediated knock-
down of MID1 in P14 CTLs reduced MTOC polarization, and
furthermore we could rescue MTOC polarization in P14MID1−/−
CTLs by inserting MID1. In contrast to the MTOC polarization
defects, the overall microtubules network seemed normal. This is
in agreement with reports describing the role of MID1 in fibrob-
lasts from Opitz patients [13] and embryonic fibroblasts from
MID1−/− mice (GM, personal communication).
The capacity of P14MID1−/− CTLs to kill target cells was
impaired and this correlated with reduced exocytosis of lytic
granules fromP14MID1−/− CTLs. Agents that depolymerizemicro-
tubules inhibit target cell killing [5, 28], which underlines the
central role of stable microtubules in trafficking of the lytic
granules to the IS [6]. Interestingly, it has been suggested that
MID1 stabilizes the microtubules during embryogenesis [13], and
we propose that one mechanism by which MID1 regulates exocy-
tosis of lytic granules is by stabilizing the microtubules in CTLs.
This is further supported by the observation that overexpres-
sion of MID1 increased exocytosis of lytic granules by approx-
imately 100% even in P14 CTLs. In contrast to the impaired
exocytosis of lytic granules, we found that secretion of IFN-γ
and TNF-α was unaffected in P14MID1−/− CTLs and by overex-
pression of MID1. This indicates that these cytokines use a dif-
ferent MID1-independent secretory pathway than lytic granules,
which is in good agreement with previous studies describing the
existence of different secretory pathways for lytic granules and
cytokines in T cells [8, 35]. Interestingly, whereas overexpres-
sion of MID1 significantly increased exocytosis of lytic granules,
it did not affect MTOC polarization in P14 CTLs. This suggests
that different MID1-mediated mechanisms regulate exocytosis of
lytic granules and polarization of the MTOC, and that these pro-
cesses can take place independently of each other as recently
suggested [36].
It is intriguing to speculate that OS patients might have a com-
promised CTL response, but very little has been published on this
matter. Most clinical reports describe the developmental anatom-
ical defects, which are the main features of the disorder. Further,
OS is diagnosed at birth or in the first years of age, but are rarely
followed up. Cases of pneumonia have been reported but they
are usually attributed to aspiration/respiratory distress probably
secondary to trachea-esophageal abnormalities (personal commu-
nications to GM).
In conclusion, our data show that MID1 is expressed in CTLs
where it controls TCR signaling, MTOC organization, and release
of cytolytic mediators. Thus, MID1 orchestrates multiple events in
CTL responses adding a novel level of regulation of CTL activation
and cytotoxicity. In addition to providing significant knowledge on
MID1 protein function in CTL biology, our study may well have
implications for regulated granule exocytosis in other cell types
such as pancreatic β-cells, natural killer cells, and mast cells, as
many of the same molecules are involved in granule exocytosis in
these cells [37, 38].
Materials and methods
Mice and cell lines
Generation of the MID1−/− mouse strain has been described [39].
The P14 mice (transgenic line 318) express the transgenic Vα2Vβ8
TCR specific for the LCMV glycoprotein gp33–41 when bound to
H-2Db [40, 41], and SMARTAmice express the transgenic Vα2Vβ8
TCR specific for the LCMV glycoprotein gp61–80 when bound to
I-Ab [42]. The MID1−/−, P14, and SMARTA strains were all on
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a C57BL/6 background. MID1−/− mice were crossed to P14 mice
to generate P14MID1−/− mice. Splenocytes from C57BL/6 mice
were used as APC. Animal experiments were approved by the
Animal Experiments Inspectorate, The Danish Ministry of Jus-
tice (approval number 2007/561–1357). EL-4 cells were cultured
in complete medium (RPMI 1640 supplemented with 10% FBS,
1% L-glutamine, 0.5 IU/L penicillin, 500 mg/L streptomycin, and
50 μM 2-ME) at 37°C in 5% CO2.
Expansion of T cells and FACS analysis
Murine P14 and P14MID1−/− CTLs were generated by stimulating
splenocytes isolated from TCR transgenic P14 and P14MID1−/−
female mice with 5 ng/mL of LCMV gp33–41 (Schafer-N) for 3
days in complete medium and subsequently resting them for 2
days as previously described [43]. For murine FACS analyses
of cell surface and intracellular molecules, we used antibodies
against CD8 (53–6.7), TCRVβ8 (F23.1), TCRVα2 (B20.1), CD62L
(MEL-14), CD44 (IM7), IFN-γ (XMG1.2), and TNF-α (MP6.XT22)
all from BD Biosciences, granzyme B (GB11, Invitrogen) and per-
forin (eBioOMAK-D, eBioscience). For phenotyping, cells from
thymus, spleen, and LNs were isolated, stained with antibodies
against CD4 (RM4–5), CD8 (53–6.7), TCRVα2 (B20.1), and CD19
(1D3) from BD Biosciences, and analyzed by FACS as previously
described [44]. For CD107a staining CTLs were restimulated for
the time indicated with 100 ng/mL gp33–41 in the presence of
CD107a-FITC antibody (1D4B from BD Biosciences) and 3 μM
monensin as previously described [29]. After incubation, the cells
were surface stained with antibodies against CD8, Vα2, and CD44
as described above.
Quantitative PCR analysis
Total RNA was extracted from thymocytes, purified na¨ıve CD4+
and CD8+ T cells, activated CD4+ T cells, and CTLs using
Trizol. Onemicrogram of total RNA from each sample was reverse-
transcribed into cDNA using RevertAid ۛ First Strand cDNA Syn-
thesis Kit (Fermentas). MID1 and β-actin gene expression was
determined using primers from TAG-Copenhagen and Stratagene
Brilliant SYBR R© Green QPCR Master Mix (Agilent Technologies).
Murine MID1 gene expression was calculated relative to β-actin
gene. Results were normalized to control conditions using the
2−Ct method [45]. Primers were MID1-forward 5′ GCT CCC
AGT AAA GAC AGA C 3′, MID1-reverse 5′ GAG CCC GTC TAG
ACC TCGC 3′, β-actin-forward 5′ AAG TGT GAC GTT GAC ATC 3′,
β-actin-reverse 5′ TGC CTG GGT ACA TGG TGG 3′.
CTL-target cell conjugation and cytotoxicity assays
For CTL-target cell conjugations assays, EL-4 cells were preincu-
bated with 0.1 μM CFSE (Invitrogen) and pulsed for 1 h with 0
or 100 ng/mL gp33–41. EL-4 cells and CTLs were mixed at a 1:1
ratio, spun down for 5 s and incubated for 15 min at 37°C. The
cells were then fixed for 10 min at 37°C with an equal volume of
4% paraformaldehyde. The cells were washed and stained with
antibodies against CD8 and analyzed by FACS. The fraction of
CTLs that formed stable conjugates with the target cells were cal-
culates as (CD8+CFSE+ events/total CD8+ events) × 100%. For
FACS-based cytotoxicity assays, EL-4 cells were pulsed with 0 or
100 ng/mL gp33–41 and used as target cells. CTLs and EL-4 cells
were mixed in 96-well round-bottomed plates at the indicated
effector to target cell ratios, spun down for 5 s and co-cultured
for the time indicated. The cells were then stained with antibodies
against CD8 and Annexin V and propidium iodide (PI) from BD
Biosciences and analyzed by FACS. The fraction of CD8− cells that
stained positive for Annexin V and/or PI was recorded as dead
target cells.
Granzyme B, IFN-γ, and TNF-α secretion
CTLs and splenocytes prepulsed with 100 ng/mL gp33–41 were
mixed, spun down for 5 s, and co-cultured for 4 h as previously
described [43]. The supernatants were harvested and the con-
centration of granzyme B, IFN-γ, and TNF-α was subsequently
measured by ELISA as described by the supplier (eBioscience).
MID1-GFP transfection and RNA interference
For MID1 overexpression studies, 5 × 106 P14 and P14MID1−/−
CTLs were resuspended in 100 μL of Amexa Mouse T cell Nucle-
ofector kit, mixed with MID1-GFP (a gift from Susann Schweiger
[13]) or control-GFP (KM28212G, SABiosciences) plasmids, and
transfected using program X-01 on the Amexa Nucleofector I
system. The cells were rested for 4 h at 37°C and subsequently
sorted on a FACS-Aria II (BD Biosciences) in an MID1-GFP+ and
an MID1-GFP− subpopulation for MID1 transfections and in a
control-GFP+ and a control-GFP− subpopulation for control-GFP
transfections. The GFP+ and GFP− CTLs were co-cultured with
splenocytes that had been pulsed with 100 ng/mL gp33–41. The
cells were incubated for 4 h, and the supernatants were subse-
quently analyzed for granzyme B, IFN-γ and TNF-α by ELISA. For
MID1 RNA interference, 5 × 106 P14 and P14MID1−/− CTLs were
resuspended in 100 μL of Amexa Mouse T-cell Nucleofector kit,
mixed with a total of 4 μg SureSilencing shRNA-MID1-GFP plas-
mids 1–4 (KM28212G, SABiosciences), and immediately trans-
fected using program X-01 on the Amexa Nucleofector I system.
The cells were rested for 24 h at 37°C and subsequently sorted on a
FACS-Aria II into shMID1-GFP+ and shMID1-GFP− subpopula-
tions. The shMID1-GFP+ and shMID1-GFP− CTLs were added to
splenocytes that had been pulsed with 100 ng/mL gp33–41. The
cells were incubated for 4 h, and the supernatants were subse-
quently analyzed for granzyme B and IFN-γ by ELISA.
Western blots
CTLs were stimulated for 0–6 h with 100 ng/mL gp33–41.
Total PP2Ac, c-Cbl, ERK1/2, S6K1, and GAPDH and phos-
phorylated ZAP70, ERK1/2, and S6K1 were determined by
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western blots as previously described [46, 47] using anti-PP2Ac
(52F8, Cell Signaling), anti-c-Cbl (7G10, Upstate Biotechnol-
ogy), anti-ERK1/2 (#9102, Cell Signaling), anti-S6K1 (49D7, Cell
Signaling), anti-GAPDH (ab9485, Abcam), anti-pZAP70 Tyr319
(#2701), anti-pERK1/2 Thr202/Tyr204 (#9101), and anti-pS6K1
Thr421/Ser424 (#9204) all from Cell Signaling. Semiquantifi-
cation was done using Fiji software and the density calculated
as (normalized band densityt = x /normalized band densityt = 0)
× 100%. PP2Ac was normalized to c-Cbl. pZAP70, pERK1/2 and
pS6K1 to GAPDH.
MTOC polarization
CTLs were resuspended in PBS supplemented with 50 nM
TubulinTrackerۛ green (Invitrogen) and plated on coverslips coated
with poly-L-lysine and anti-CD3 antibodies (145-2C11, BD Bio-
sciences). The cells were kept at 37°C and z-stacks were acquired
using a Zeiss Cell Observer with spinning disc and a 100×/
1.46 NA oil objective. The z-stacks were blinded, the absolute
position of the MTOC found and scored from 0 to 1 relative to
the cell size. A low number indicates MTOC polarization toward
the coverslip, whereas a high number indicates MTOC positioning
away from the coverslip as depicted in Figure 3E.
Statistical analysis
Statistical analyses were performed using Student’s t-test with a
5% significance level, unpaired observations, and equal variance.
MTOC statistical analyses were performed using Mann–Whitney
nonparametric test.
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